- Home
- VNRX vs CRVO Comparison
VNRX vs CRVO Comparison
Compare VNRX & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNRX
- CRVO
- Stock Information
- Founded
- VNRX N/A
- CRVO 2001
- Country
- VNRX United States
- CRVO United States
- Employees
- VNRX N/A
- CRVO N/A
- Industry
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- VNRX Health Care
- CRVO Health Care
- Exchange
- VNRX Nasdaq
- CRVO Nasdaq
- Market Cap
- VNRX 68.3M
- CRVO 67.4M
- IPO Year
- VNRX N/A
- CRVO N/A
- Fundamental
- Price
- VNRX $0.60
- CRVO $10.51
- Analyst Decision
- VNRX Strong Buy
- CRVO Strong Buy
- Analyst Count
- VNRX 4
- CRVO 6
- Target Price
- VNRX $3.50
- CRVO $20.80
- AVG Volume (30 Days)
- VNRX 196.8K
- CRVO 119.1K
- Earning Date
- VNRX 08-14-2025
- CRVO 08-08-2025
- Dividend Yield
- VNRX N/A
- CRVO N/A
- EPS Growth
- VNRX N/A
- CRVO N/A
- EPS
- VNRX N/A
- CRVO N/A
- Revenue
- VNRX $1,319,252.00
- CRVO $7,776,968.00
- Revenue This Year
- VNRX $274.46
- CRVO N/A
- Revenue Next Year
- VNRX $212.60
- CRVO N/A
- P/E Ratio
- VNRX N/A
- CRVO N/A
- Revenue Growth
- VNRX 35.10
- CRVO N/A
- 52 Week Low
- VNRX $0.40
- CRVO $1.80
- 52 Week High
- VNRX $0.94
- CRVO $20.63
- Technical
- Relative Strength Index (RSI)
- VNRX 39.24
- CRVO 63.06
- Support Level
- VNRX $0.64
- CRVO $9.61
- Resistance Level
- VNRX $0.73
- CRVO $10.89
- Average True Range (ATR)
- VNRX 0.04
- CRVO 0.67
- MACD
- VNRX -0.00
- CRVO 0.04
- Stochastic Oscillator
- VNRX 19.34
- CRVO 70.28
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.